...
首页> 外文期刊>Clinical kidney journal. >Seventy-seven kidney paired donation transplantations at a single transplant centre in India led to an increase in living donor kidney transplantations in 2015
【24h】

Seventy-seven kidney paired donation transplantations at a single transplant centre in India led to an increase in living donor kidney transplantations in 2015

机译:2015年,在印度的单个移植中心进行了77次肾脏配对捐赠移植,导致活体供体肾脏移植数量增加

获取原文
           

摘要

Background To ascertain the validity of kidney paired donations (KPDs) as an alternative strategy for increasing living donor kidney transplantations (LDKTs) in an LDKT-dominated transplant programme since directed kidney transplantation, ABO-incompatible or crossmatch-positive pairs are not feasible due to costs and infectious complications. Methods This was a prospective single-centre study of 77 KPD transplantations (25 two-way, 7 three-way and 1 six-way exchange) from 1 January 2015 to 1 January 2016 of 158 registered donor recipient pairs. During this period, a total of 380 kidney transplantations [71 deceased donor kidney transplantations (DDKTs), 309 LDKTs] were performed. The reasons for opting for KPD were ABO incompatibility ( n =?45), sensitization ( n =?26) and better matching ( n =?6). Results KPD matching was facilitated in 62% ( n =?98) of transplants. In all, 48.7% ( n =?77) of the transplants were completed in 2015, whereas 13.3% ( n =?21) of the matched patients were to undergo transplant surgery in early 2016 after getting legal permission. The waiting time for KPD was shorter compared with DDKT. The death-censored graft survival and patient survival were 98.7% ( n =?76) and 93.5% ( n =?72), respectively. In all, 14.2% ( n =?11) of patients had acute rejection. Match rates among sensitized ( n =?60) and O group patients ( n =?62) were 58.3% ( n =?35) and 41.9% ( n =?26), respectively. Of these, 43.3% ( n =?26) and 29% ( n =?18) of transplants were completed and 15% ( n =?9) and 12.9% ( n =?8), respectively, are waiting for legal permission. Conclusions LDKT increased by 25% in 1 year in our single-centre KPD programme. Our key to success was the formation of a KPD registry, awareness and active counselling programs and developing a dedicated team.
机译:背景技术为了确定在以LDKT为主导的移植计划中,肾脏配对捐赠(KPD)作为增加活体供体肾脏移植(LDKT)的替代策略的有效性,因为直接肾脏移植,ABO不相容或交叉匹配阳性对是不可行的,因为费用和感染并发症。方法这是一项前瞻性单中心研究,从2015年1月1日至2016年1月1日对158个注册的供体对进行了77次KPD移植(25次2次,7次3次和1次6次互换)。在此期间,总共进行了380例肾脏移植[71例死者的供体肾脏移植(DDKT),309例LDKT]。选择KPD的原因是ABO不相容(n =?45),敏化度(n =?26)和更好的匹配度(n =?6)。结果62%(n = 98)的移植促进了KPD匹配。总共有48.7%(n =?77)的移植手术于2015年完成,而13.3%(n =?21)的匹配患者在获得法律许可后于2016年初接受移植手术。与DDKT相比,KPD的等待时间更短。死亡检查的移植物存活率和患者存活率分别为98.7%(n =?76)和93.5%(n =?72)。总共有14.2%(n =?11)的患者患有急性排斥反应。致敏(n = 60)和O组患者(n = 62)的匹配率分别为58.3%(n = 35)和41.9%(n = 26)。其中,完成移植的有43.3%(n =?26)和29%(n =?18),分别有15%(n =?9)和12.9%(n =?8)等待法律许可。 。结论在我们的单中心KPD计划中,LDKT在1年中增加了25%。我们成功的关键是建立KPD注册中心,提高认识和积极的咨询计划以及建立一支敬业的团队。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号